Cingulate Inc. (NASDAQ:CINGW) Short Interest Up 662.1% in January

Cingulate Inc. (NASDAQ:CINGW) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 13,862 shares, an increase of 662.1% from the December 31st total of 1,819 shares. Based on an average trading volume of 83,296 shares, the short-interest ratio is presently 0.2 days. Based on an average trading volume of 83,296 shares, the short-interest ratio is presently 0.2 days.

Cingulate Trading Up 0.1%

NASDAQ:CINGW traded up $0.00 during mid-day trading on Thursday, hitting $0.09. The company had a trading volume of 10,000 shares, compared to its average volume of 66,516. The business’s fifty day moving average is $0.06 and its two-hundred day moving average is $0.06. Cingulate has a fifty-two week low of $0.02 and a fifty-two week high of $0.18.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.